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implemented in individual centers before post data collection.
Algorithms were evaluated by comparing contrast media
wastage pre and post introduction of gadopentetate dimeglumine
PBP. RESULTS: Following recommended optimal algorithm that
included gadopentetate dimeglumine PBP, contrast media
wastage was reduced from 7.5% of the total contrast media used
to 5.8% (p = 0.078). The per-scan contrast media wastage
became highly correlated with average number of daily scans
(corr = −0.8) after introduction of PBP (corr < 0.01 before PBP).
Our ﬁndings are consistent with a study conducted by Duke Uni-
versity Medical Center (DUMC) that showed signiﬁcant cost
savings using gadopentetate dimeglumine PBP in a large acade-
mic center. All centers in this study were smaller than DUMC,
with annual contrast media usage between 8000 and 27,000
mLs. CONCLUSION: Using the time in motion methodology
proved to be an effective tool in measuring MR contrast media
wastage.
PMC8
CREATING KNOWLEDGE ABOUT ADVERSE DRUG
REACTIONS:A CRITICAL ANALYSIS OF THE DANISH
REPORTING SYSTEM FROM 1968 TO 2005
Aagaard L1, Soendergaard B2, Hansen EH2
1University of Copenhagen, Copenhagen, Denmark, 2Danish
University of Pharmaceutical Sciences, Copenhagen, Denmark
OBJECTIVES: The purpose of this article was to explore knowl-
edge created by the system, including how the collected data have
been used to monitor the safety of licensed drugs. Nonakas
theory of knowledge creation was used to discriminate between
tacit and explicit knowledge. METHODS: Our analysis is based
on data from the Danish reporting system for ADRs which was
established in 1968. RESULTS: Totally 56,802 ADR case reports
were received from 1968 to 2005. The analysis shows a rather
stable number of ADR cases from 1980 with about 2000 reports
per year. The distribution of cases into serious to non-serious
ADRs has been one to four throughout the period under study
but with large variations. Analysis of selected ADR cases shows
that the system lacked potential to capture available knowledge.
Consequently the ADR reports have been of limited value and
signiﬁcance in the process of creating scientiﬁc knowledge.
CONCLUSION: Thus the analysis questions the way available
data can become explicit as basis for legal actions knowledge,
and whether all data can become knowledge, including who
decides what knowledge is.
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OBJECTIVES: To study literary data about pharmacoeconomic
investigation published in Russian Federation and to analyse the
dynamics and structures of available publications. METHODS:
The screening of all pharmacoeconomic researches published in
RF from 1995 to 2005, obtainable from database “Russian Med-
icine” GNCMB MMA. RESULTS: There are 236 sources were
found and analysed in all. The growth trend from year to year
since 1995 was clearly recognized. It is possible to divide all pub-
lications into three main groups: pharmacoeconomic investiga-
tions “properly” transacted in RF, using standard methods
−65%, translation foreign researches into Russian −2% and
researches, describes methods of pharmacoeconomic investiga-
tions −33%. Majority of publications was published in periodi-
cals (in journals −77%). Structure of published investigations
was: monocenter −81%, multicenter Russian −14%, data about
number of centers wasn’t marked −4% and multicenter interna-
tional—only 1%. Directedness of investigations was: retrospec-
tive (43%), prospective (25%), data about directedness wasn’t
marked −14%. Design of investigations was: randomized −25%,
blind −2%, placebo-controlled −6% and in 67% data about
number of centers wasn’t marked. Between using methods of
analysis were prevail “cost-of-illness” and “cost-effectiveness”.
Modeling used only in 43 investigations. In most cases (73%)
only direct costs was discounted. Both direct and indirect costs
discounted in 16% of investigations. In a number of cases
authors didn’t indicate kind of using costs. Between nosologic
units more frequently found: cardiovascular—a third (64), then
pulmonology, psychiatric, neurology disorders and public health
organization. CONCLUSION: Pharmacoeconomics, as a scien-
tiﬁc and practical direction of Russian health care, is developing
successfully. Introduction in medical practice recommendation
based on pharmacoeconomic analysis will promote optimization
of pharmacotherapy due to denial of using ineffective and inse-
cure drug, more active using new drugs with proven expediency
of it’s using, and rational spending of limited health care
resources.
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OBJECTIVES: Medicaid administrative ﬁles are an important
data source to study the impact and consequences of diseases
and treatments. The quality of the information available in Med-
icaid enrollment data though has not been systematically
assessed. We evaluated the quality of Medicaid demographic
information for epidemiological and health services analysis by
assessing variation across years. We also assessed the quality of
SSN, differences in data quality across states, continuity and
length of enrollment in the Medicaid program, and the quality
of mortality information in Medicaid data. METHODS: We
used Medicaid eligibility ﬁles from six states for the 5 year period
from 1996 to 2000. We summarized the demographic charac-
teristics across the six states, and estimated the percentage of
people with missing, unknown and multiple entries for demo-
graphic characteristics. We also checked the continuity of enroll-
ment in Medicaid by estimating the average length of enrollment
and average number of episodes. We estimated percentage of
records with missing SSN, multiple SSN for those enrolled for at
least two years, or the same SSN across the different states. We
also compared mortality information reported in the Medicaid
database with death certiﬁcate data for one state. RESULTS: The
results indicate that there are very few cases with missing date
of birth or sex in any state. The availability of information on
beneﬁciary race (range of unknown race from 1.1% to 6.9%)
and the reporting of social security numbers (range of missing
from 0.4% to 32.9%) though do vary substantially across the
states. Using Medicaid data only, 31.7% of the deaths would not
have been identiﬁed. CONCLUSION: Overall, Medicaid data-
bases, enhanced with death certiﬁcate data, can provide high
quality information for analysis. The quality of data available
does vary across states and therefore particular attention should
be placed in selecting appropriate states that will yield high
quality data for analysis.
